Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

NCT02118012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Chlorcyclizine HCl
DRUG: Ribavirin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)